ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 141 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $48,000 | -18.6% | 13,200 | -34.0% | 0.00% | -50.0% |
| Q1 2019 | $59,000 | -58.5% | 19,998 | -77.5% | 0.00% | -71.4% |
| Q4 2018 | $142,000 | +238.1% | 88,995 | +687.0% | 0.01% | +250.0% |
| Q3 2018 | $42,000 | -71.4% | 11,308 | -78.2% | 0.00% | -71.4% |
| Q2 2018 | $147,000 | +188.2% | 51,910 | +193.4% | 0.01% | +133.3% |
| Q4 2017 | $51,000 | -25.0% | 17,692 | +112.1% | 0.00% | -25.0% |
| Q3 2016 | $68,000 | -21.8% | 8,340 | -24.9% | 0.00% | -20.0% |
| Q2 2016 | $87,000 | +1.2% | 11,098 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $86,000 | -28.3% | 11,098 | 0.0% | 0.01% | -28.6% |
| Q4 2015 | $120,000 | +55.8% | 11,098 | 0.0% | 0.01% | +75.0% |
| Q3 2015 | $77,000 | -21.4% | 11,098 | 0.0% | 0.00% | -20.0% |
| Q2 2015 | $98,000 | -84.8% | 11,098 | -83.0% | 0.01% | -83.9% |
| Q1 2015 | $643,000 | +312.2% | 65,240 | +413.4% | 0.03% | +287.5% |
| Q4 2014 | $156,000 | -83.7% | 12,707 | -86.7% | 0.01% | -86.2% |
| Q3 2014 | $957,000 | +369.1% | 95,892 | +256.0% | 0.06% | +383.3% |
| Q2 2014 | $204,000 | – | 26,937 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 5,191,600 | $8,255,000 | 4.47% |
| RTW INVESTMENTS, LP | 13,749,383 | $21,862,000 | 2.04% |
| ARMISTICE CAPITAL, LLC | 4,300,000 | $6,837,000 | 0.52% |
| DAFNA Capital Management LLC | 630,182 | $1,002,000 | 0.50% |
| Rock Springs Capital Management LP | 2,325,000 | $3,697,000 | 0.18% |
| 683 Capital Management, LLC | 1,000,000 | $1,590,000 | 0.10% |
| Alambic Investment Management, L.P. | 133,698 | $213,000 | 0.09% |
| South Dakota Investment Council | 3,037,004 | $7,310,000 | 0.08% |
| Alpine Global Management, LLC | 205,172 | $326,000 | 0.08% |
| Rhenman & Partners Asset Management AB | 402,800 | $640,000 | 0.07% |